[Cardiovasc Res 2019;115:854–868].
The authors of the above paper wish to advise that references to Rituximab have been added to the paper. The content of the article has been edited to reflect this change.
The authors apologise for the error.
. 2018 Apr 8;115(5):868. doi: 10.1093/cvr/cvz082
Corrigendum to: Cardiovascular toxicities associated with immune checkpoint inhibitors
Issue date 2019 Apr 15.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
PMCID: PMC6735754 PMID: 30958559
This corrects the article "Cardiovascular toxicities associated with immune checkpoint inhibitors" on page 854.